Caffa et al. found that combining a periodic or fasting-mimicking diet (FMD) with hormone therapy, specifically fulvestrant and tamoxifen, enhanced anticancer effects in ER+ breast cancer mouse models by reducing leptin, insulin, and IGF-1 levels. Here, IGF1 is linked to breast carcinoma.